PMID- 17301181 OWN - NLM STAT- MEDLINE DCOM- 20070313 LR - 20200225 IS - 1529-2401 (Electronic) IS - 0270-6474 (Print) IS - 0270-6474 (Linking) VI - 27 IP - 7 DP - 2007 Feb 14 TI - Proteolytic activation of monocyte chemoattractant protein-1 by plasmin underlies excitotoxic neurodegeneration in mice. PG - 1738-45 AB - Exposure of neurons to high concentrations of excitatory neurotransmitters causes them to undergo excitotoxic death via multiple synergistic injury mechanisms. One of these mechanisms involves actions undertaken locally by microglia, the CNS-resident macrophages. Mice deficient in the serine protease plasmin exhibit decreased microglial migration to the site of excitatory neurotransmitter release and are resistant to excitotoxic neurodegeneration. Microglial chemotaxis can be signaled by the chemokine monocyte chemoattractant protein-1 (MCP-1)/CCL2 (CC chemokine ligand 2). We show here that mice genetically deficient for MCP-1 phenocopy plasminogen deficiency by displaying decreased microglial recruitment and resisting excitotoxic neurodegeneration. Connecting these pathways, we demonstrate that MCP-1 undergoes a proteolytic processing step mediated by plasmin. The processing, which consists of removal of the C terminus of MCP-1, enhances the potency of MCP-1 in in vitro migration assays. Finally, we show that infusion of the cleaved form of MCP-1 into the CNS restores microglial recruitment and excitotoxicity in plasminogen-deficient mice. These findings identify MCP-1 as a key downstream effector in the excitotoxic pathway triggered by plasmin and identify plasmin as an extracellular chemokine activator. Finally, our results provide a mechanism that explains the resistance of plasminogen-deficient mice to excitotoxicity. FAU - Sheehan, John J AU - Sheehan JJ AD - Department of Pharmacological Sciences and Program in Molecular and Cellular Pharmacology, Stony Brook University, Stony Brook, New York 11794-8651, USA. FAU - Zhou, Chun AU - Zhou C FAU - Gravanis, Iordanis AU - Gravanis I FAU - Rogove, Andrew D AU - Rogove AD FAU - Wu, Yan-Ping AU - Wu YP FAU - Bogenhagen, Daniel F AU - Bogenhagen DF FAU - Tsirka, Stella E AU - Tsirka SE LA - eng GR - 5R01ES01203904/ES/NIEHS NIH HHS/United States GR - 5R01NS04216804/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - United States TA - J Neurosci JT - The Journal of neuroscience : the official journal of the Society for Neuroscience JID - 8102140 RN - 0 (Antigens, Differentiation) RN - 0 (Chemokine CCL2) RN - 0 (Fibrinolytic Agents) RN - 0 (monocyte-macrophage differentiation antigen) RN - 147336-22-9 (Green Fluorescent Proteins) RN - EC 3.4.21.7 (Fibrinolysin) RN - K3Z4F929H6 (Lysine) RN - SIV03811UC (Kainic Acid) SB - IM MH - Analysis of Variance MH - Animals MH - Antigens, Differentiation/metabolism MH - Blotting, Western/methods MH - Cell Line MH - Cell Movement/drug effects MH - Chemokine CCL2/deficiency/*drug effects/*metabolism MH - Drug Interactions MH - Enzyme-Linked Immunosorbent Assay/methods MH - Fibrinolysin/*pharmacology MH - Fibrinolytic Agents/*pharmacology MH - Gene Expression Regulation/drug effects/physiology MH - Green Fluorescent Proteins/metabolism MH - Hippocampus/drug effects/metabolism MH - In Situ Nick-End Labeling/methods MH - Kainic Acid MH - Lysine/metabolism MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Microglia/drug effects MH - Neurodegenerative Diseases/chemically induced/*metabolism/pathology MH - Time Factors MH - Transfection PMC - PMC6673734 EDAT- 2007/02/16 09:00 MHDA- 2007/03/14 09:00 PMCR- 2007/08/14 CRDT- 2007/02/16 09:00 PHST- 2007/02/16 09:00 [pubmed] PHST- 2007/03/14 09:00 [medline] PHST- 2007/02/16 09:00 [entrez] PHST- 2007/08/14 00:00 [pmc-release] AID - 27/7/1738 [pii] AID - 3188416 [pii] AID - 10.1523/JNEUROSCI.4987-06.2007 [doi] PST - ppublish SO - J Neurosci. 2007 Feb 14;27(7):1738-45. doi: 10.1523/JNEUROSCI.4987-06.2007.